Nasopharyngeal carriage of Haemophilus influenzae among adults with co-morbidities.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
31 01 2022
Historique:
received: 08 06 2021
revised: 26 10 2021
accepted: 12 12 2021
pubmed: 26 12 2021
medline: 27 1 2022
entrez: 25 12 2021
Statut: ppublish

Résumé

After the widespread use of Haemophilus influenzae type b (Hib) vaccine, H. influenzae invasive disease is now commonly due to non-encapsulated (NTHi), affecting mostly the youngest and the elderly. The objective of this study was to investigate H. influenzae nasopharyngeal carriage rate in adults with co-morbidities and possible associated risk factors. Patients aged >50 years with co-morbidities attending medical centres were examined. A nasopharyngeal swab was analysed for H. influenzae presence by cultural and molecular methods (RT-PCR). Univariable and multivariable analysis of risk factors for H. influenzae carriage were performed. Serotype of isolates was determined by PCR capsular genotyping. Minimum inhibitory concentration (MIC) was determined by MIC gradient test and β-lactamase production was detected by the nitrocephin test. Genotyping was performed by Multilocus sequence typing (MLST). Phylogenetic relationships among carriage and invasive NTHi strains were assessed. Among 248 enrolled patients (median age: 73 years), the carriage rate was 5.6% and 10.5% by cultural method or RT-PCR, respectively. Colonization with H. influenzae was significantly associated with the presence of acute respiratory symptoms (adjusted OR = 12.16, 95% CI: 3.05-48.58, p < 0.001). All colonizing isolates were NTHi. Three isolates (3/14, 21.4%) were resistant to ampicillin and beta-lactamase positive. MLST revealed a high degree of genetic diversity, with 11 different STs from 14 isolates. Eight out of the 11 (72.7%) STs were shared among carriage and invasive isolates. Adults ≥50 years old with co-morbidities are occasionally colonized by H. influenzae, even if the presence of co-morbidities is not a risk factor for colonization. The presence of acute respiratory symptoms is the only factor associated with H. influenzae colonization. Colonizing H. influenzae are all NTHi. Colonizing H. influenzae often belong to the same STs of invasive disease isolates.

Identifiants

pubmed: 34952754
pii: S0264-410X(21)01633-9
doi: 10.1016/j.vaccine.2021.12.030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

826-832

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maria Giufrè (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: maria.giufre@iss.it.

Maria Dorrucci (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Alessandra Lo Presti (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Francesca Farchi (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Rita Cardines (R)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Romina Camilli (R)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Fernanda Pimentel de Araujo (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Fabiola Mancini (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Alessandra Ciervo (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Maria Corongiu (M)

Italian Federation of General Practitioners (Federazione Italiana Medici di Medicina Generale, FIMMG), Rome, Italy.

Annalisa Pantosti (A)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Italian Federation of General Practitioners (Federazione Italiana Medici di Medicina Generale, FIMMG), Rome, Italy.

Marina Cerquetti (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Catia Valdarchi (C)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Italian Federation of General Practitioners (Federazione Italiana Medici di Medicina Generale, FIMMG), Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH